CVS Health Corp vs Eos Energy Enterprises Inc — how do they compare? CVS Health Corp trades at $104.86 (market cap $135.48B), while Eos Energy Enterprises Inc trades at $4.31 (market cap $1.52B). The key difference: CVS Health Corp is far larger — about 89.1× Eos Energy Enterprises Inc's market cap, and CVS Health Corp pays a 2.51% dividend while Eos Energy Enterprises Inc pays none. Which is the better fit depends on your goals.
| CVS | EOSE | |
|---|---|---|
Market Cap | $135.48B | $1.52B |
Sector | Health | Energy |
52-Week High | $106.18 | $19.19 |
52-Week Low | $58.75 | $4.29 |
Enterprise Value | $202.02B | $1.75B |
Dividend Yield | 2.51% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
Eos Energy Enterprises (EOSE) trades at $4.35, down 1.14% on the day, amid a bearish technical trend and challenging fundamentals. The company reported a net loss of $969.65 million on $114.20 million in revenue for 2025, with negative gross and net profit margins. However, recent news highlights project wins, including a 400 MWh battery storage selection, and a $125 million investment for its Frontier Power USA platform, signaling growth potential in the long-duration energy storage market.
The outlook is a balance of high execution risk against significant growth opportunity. While analyst consensus is a 'Hold' with a $8.40 price target, the company's path to profitability remains uncertain. Key risks include persistent cash burn and high debt-to-asset ratio, but successful commercialization of its zinc-based battery technology could drive substantial upside from current levels.
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Eos Energy Enterprises provides long-duration energy storage solutions. Its signature zinc-based batteries are designed for utility-scale applications, helping to stabilize power grids and integrate renewable energy.
Read more on EOSE →